Sriram Subramonia1, Sarah Pankhurst, Brian J Rowlands, Dileep N Lobo. 1. Division of Gastrointestinal Surgery, Nottingham Digestive Diseases Centre Biomedical Research Unit, Nottingham University Hospitals, Queen's Medical Centre, Nottingham, NG7 2UH, UK.
Abstract
BACKGROUND: We aimed to study outcome in patients with an open abdomen in whom the abdominal vacuum-assisted closure system (V.A.C.((R)) Therapy()) was used to provide temporary cover and achieve wound closure. METHODS: All patients in whom V.A.C. Therapy was used to manage laparotomy wounds between February 2006 and May 2007 at a University Teaching Hospital were followed up prospectively until successful completion or stoppage of V.A.C. Therapy. RESULTS: Of the 51 consecutive patients (33 male), V.A.C. Therapy was used to manage a laparostomy in 10 patients and abdominal wound dehiscence in 41. Median (IQR) duration of V.A.C. Therapy was 17 (7-26) days. Wound healing was achieved in 31 (61%) patients, four of whom had additional surgery to assist wound closure. The rest healed by secondary intention. Treatment was withdrawn due to therapy-related complications in nine patients and due to medical or logistical reasons in seven. Four patients died while on therapy. While most V.A.C. Therapy-related problems were minor, two patients developed enteric fistulae that necessitated surgical repair. At a median (IQR) follow-up of 8 (4-13) months, 18 patients had stable cutaneous coverage with no incisional hernia, 12 developed an incisional hernia, 9 were lost to follow-up, and 12 died. CONCLUSIONS: V.A.C. Therapy is a useful adjunct in the management of the open abdomen and should be considered in the treatment of this problem. Restoration of cutaneous and fascial integrity of the abdominal wall, the risk of fistulisation, and the cost-effectiveness of this therapy require further evaluation.
BACKGROUND: We aimed to study outcome in patients with an open abdomen in whom the abdominal vacuum-assisted closure system (V.A.C.((R)) Therapy()) was used to provide temporary cover and achieve wound closure. METHODS: All patients in whom V.A.C. Therapy was used to manage laparotomy wounds between February 2006 and May 2007 at a University Teaching Hospital were followed up prospectively until successful completion or stoppage of V.A.C. Therapy. RESULTS: Of the 51 consecutive patients (33 male), V.A.C. Therapy was used to manage a laparostomy in 10 patients and abdominal wound dehiscence in 41. Median (IQR) duration of V.A.C. Therapy was 17 (7-26) days. Wound healing was achieved in 31 (61%) patients, four of whom had additional surgery to assist wound closure. The rest healed by secondary intention. Treatment was withdrawn due to therapy-related complications in nine patients and due to medical or logistical reasons in seven. Four patients died while on therapy. While most V.A.C. Therapy-related problems were minor, two patients developed enteric fistulae that necessitated surgical repair. At a median (IQR) follow-up of 8 (4-13) months, 18 patients had stable cutaneous coverage with no incisional hernia, 12 developed an incisional hernia, 9 were lost to follow-up, and 12 died. CONCLUSIONS: V.A.C. Therapy is a useful adjunct in the management of the open abdomen and should be considered in the treatment of this problem. Restoration of cutaneous and fascial integrity of the abdominal wall, the risk of fistulisation, and the cost-effectiveness of this therapy require further evaluation.
Authors: Daniel Perez; Stefan Wildi; Nicolas Demartines; Matthias Bramkamp; Christian Koehler; Pierre-Alain Clavien Journal: J Am Coll Surg Date: 2007-10 Impact factor: 6.113
Authors: D Sermoneta; M Di Mugno; P L Spada; C Lodoli; M E Carvelli; S C Magalini; C Cavicchioni; M G Bocci; F Martorelli; M G Brizi; D Gui Journal: Int Wound J Date: 2010-08-19 Impact factor: 3.315
Authors: Julia Mees; Wolf Arif Mardin; Norbert Senninger; Matthias Bruewer; Daniel Palmes; Soeren Torge Mees Journal: Langenbecks Arch Surg Date: 2012-08-10 Impact factor: 3.445
Authors: M López-Cano; J M García-Alamino; S A Antoniou; D Bennet; U A Dietz; F Ferreira; R H Fortelny; P Hernandez-Granados; M Miserez; A Montgomery; S Morales-Conde; F Muysoms; J A Pereira; R Schwab; N Slater; A Vanlander; G H Van Ramshorst; F Berrevoet Journal: Hernia Date: 2018-09-03 Impact factor: 4.739
Authors: Ilker Uçkay; Americo Agostinho; Wilson Belaieff; Laurence Toutous-Trellu; Saja Scherer-Pietramaggiori; Axel Andres; Louis Bernard; Hubert Vuagnat; Pierre Hoffmeyer; Blaise Wyssa Journal: World J Surg Date: 2011-05 Impact factor: 3.352
Authors: Sullivan A Ayuso; Sharbel A Elhage; Bola G Aladegbami; Angela M Kao; Kent W Kercher; Paul D Colavita; Vedra A Augenstein; B Todd Heniford Journal: Surg Endosc Date: 2021-05-20 Impact factor: 4.584